Key products
Illuccix™
I-131 Oral Solution
F-18 FDG
Galli Eo™ Ga-68 Generator and Accessories
NeuraCeq™
NaF Plus
Isologic Pyrophosphate Injection Kit
IlluccixTM
Isologic distributes Illuccix™ vials and unit doses
After radiolabeling with Ga-68, Illuccix™ is indicated for positron emission tomography (PET) imaging of prostate-specific membrane antigen (PSMA)-positive lesions in men with prostate cancer. It is used for patients with suspected metastasis who are candidates for initial definitive therapy, those with suspected recurrence indicated by elevated serum prostate-specific antigen (PSA) levels, and for identifying patients with progressive metastatic castration-resistant prostate cancer (mCRPC) who may be eligible for PSMA-targeted therapy. Illuccix™ is administered as a slow intravenous bolus injection, followed by an intravenous flush of sterile 0.9% sodium chloride injection to ensure complete dose delivery.
I-131 Oral Solution
Isologic’s radioactive iodine solution is used in the production of diagnostic and therapeutic capsules.
Radioactive iodine is used for the treatment and diagnosis of thyroid cancer.
The treatment consists of ablating the normal thyroid tissue remaining after surgery, facilitating long-term monitoring of cancer progression or spread. Ablation also improves the efficacy of subsequent radioactive iodine treatments, enabling higher doses to be administered if necessary. It can also be used as an adjunctive treatment that helps detect and eliminate suspected residual disease and distal metastases, reducing the risk of relapses or recurrence of differentiated thyroid cancer.
Diagnostic formulations are used, in the event of thyroid cancer recurrence, for thyroid uptake studies, enabling clinicians to assess thyroid function and guide subsequent therapeutic decisions.
F-18 FDG
F-18 FDG is indicated for imaging in patients undergoing diagnostic oncological procedures for the evaluation of single pulmonary nodules (diagnosis), acute and chronic infections (such as abscesses, tuberculosis, and histoplasmosis), inflammatory/granulomatous conditions (such as sarcoidosis, pleurodesis and bronchiectasis, radiation therapy sites), and atherosclerotic vessels that might mimic tumor accumulation.
Galli Eo™ Ga-68 Generator and Accessories
The Galli Demo® is a non-radioactive demonstration device that allows users to train staff on the handling and operation of the generator in a safe, radiation-free environment, ensuring smooth integration and readiness for clinical use.
The Galli Cap® is the user interface and control system for operating the Galli Eo™ Ga-68 Generator, enabling automated and guided elution of Ga-68 for radiopharmaceutical preparation.
The Galli Up® is an accessory stand designed to securely hold the Galli Eo™ Ga-68 Generator in a vertical position during operation to help users optimize their workspace.
The Galli Mov® is a rolling support designed to fit to the generator base to allow easy movement within a hot cell.
The Galli Eo™ Ga-68 generator connected to the Galli Cap®
NeuraCeq™
Isologic produces and distributes NeuraCeq™ across Canada.
NeuraCeq™ is a radioactive diagnostic agent indicated for positron emission tomography (PET) imaging of the brain to estimate β-amyloid neuritic plaque density in adult patients with cognitive impairment who are being evaluated for Alzheimer’s disease (AD) and other causes of cognitive decline.
NaF Plus
NaF Plus Injection is indicated as an accessory to positron emission tomography (PET) for the detection of areas of altered osteogenesis associated with bone metastases.
Isologic Pyrophosphate Injection Kit
Isologic Pyrophosphate Injection Kit is used as an adjunct to sodium pertechnetate (TC-99m) in adults for blood pool imaging, including gated blood pool imaging, and for detecting gastrointestinal bleeding. It is indicated for detecting areas of altered osteogenesis and assisting in the diagnosis of myocardial infarction, confirmed by ECG and serum enzyme testing when reconstituted with sodium pertechnetate (TC-99m).